Trial Profile
Pharmacokinetics and pharmacodynamics of recombinant parathyroid hormone in patients with hypoparathyroidism
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Parathyroid hormone (Primary)
- Indications Hypoparathyroidism
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 11 Dec 2015 New trial record